Article
GH safety workshop position paper: a critical appraisal of recombinant human GH therapy in children and adults
13 Nov 2015
Abstract excerpt
Recombinant human GH (rhGH) has been in use for 30 years, and over that time its safety and efficacy in children and adults has been subject to considerable scrutiny. In 2001, a statement from the GH Research Society (GRS) concluded that 'for approved indications, GH is safe'; however, the statement highlighted a number of areas for on-going surveillance of long-term safety, including cancer risk, impact on...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
